Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

LGL leukemia patients exhibit substantial protective humoral responses following SARS‐CoV‐2 vaccination

eJHaem(2022)10.1002/jha2.472Source: DataRank Database

LGL leukemia patients exhibit substantial protective humoral responses following SARS‐CoV‐2 vaccination is a research paper published in eJHaem (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.10)OA: goldTopics (25)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Omar Elghawy ORCID,Bryna C. Shemo ORCID,Thomas P. Loughran ORCID,David J. Feith ORCID,HeeJin Cheon ORCID

Live enrichment

PubMed:35941882 PMC:PMC9348025 OpenAlex:https://openalex.org/W4281649854

National Institutes of Health

Grant: R01CA178393

NHLBI NIH HHS

Grant: R01 HL136314

NIGMS NIH HHS

Grant: T32 GM007267

NHLBI NIH HHS

Grant: T32 HL007284

NCI NIH HHS

Grant: P30 CA044579

National Institutes of Health

Grant: 5R01CA178393-05

Genomic Architecture of LGL Leukemia

National Cancer Institute

FWCI

0.10

Citation Percentile

0.4%

Citation Trend

2023

goldLicense: cc-by

journalhttps://doi.org/10.1002/jha2.472

publisherhttps://doi.org/10.1002/jha2.472

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.472

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/jha2.472

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35941882

Fields of Study

SARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesCytokine Signaling Pathways and Interactions0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

LeukemiaImmunologyVaccinationVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakOutbreakDiseaseInfectious disease (medical specialty)Internal medicineLeukaemiaBlood diseasesHaematological MalignanciesLymphoid MalignanciesShort ReportsDiseases of the blood and blood-forming organsRC633-647.5

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being